U.S. Cartilage Repair Market to Grow 6.8% Over Next 4 Years

BioMedGPS, a provider of online business intelligence for life science executives, reports that the U.S. market for cartilage repair and replacement technologies will reach $44.5 million in 2010 and grow at a rate of 6.8 percent to $57.9 million in 2014, according to a BioMedGPS news release.

The company's SmartTRAK OrthoBio database indicates that more than 10 cartilage replacement technologies may be on the U.S. market by 2014, fueling growth in this arena in the latter half of the decade, according to the release. The OrthoBio: Cartilage module is part of the SmartTRAK Online Business Intelligence platform, which provides realtime business intelligence and analysis on medical device markets, companies and products that is updated daily as events in the industry occur.

"Cartilage replacement represents an enormous untapped opportunity, since many of the current treatments are palliative in nature and a cartilage injury often initiates the cascade of events that leads to degenerative joint disease," Sharon O'Reilly, founder, president and CEO of BioMedGPS, said in the release. "Many of the emerging companies developing technologies including stem cells, growth factors and synthetic joint resurfacing are profiled in the SmartTRAK OrthoBio: Cartilage database. . .Already, three acquisitions have occurred in the cartilage replacement arena in the last year and there are likely more to come."

Read the BioMedGPS release on the U.S. cartilage repair market (pdf).